Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Premia Spine, Ltd.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Premia Spine, Ltd.

Regulatory records
4
Linked recall entries
1
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Premia Spine, Ltd.. It includes 1 original PMA approval. 1 entry is a PMA supplement. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Jun 15, 2023 to Sep 9, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code QWK appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P220002, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 7 Giborey Israel St., Ramat Poleg, Netanya, 4250407. Recorded on P220002/S011, decision dated Sep 9, 2026.

Changes described in PMA records

P220002/S011: TOPS System

Premia Spine, Ltd. holds PMA P220002/S011 for the TOPS™ System, a posterior spinal element prosthesis (product code QWK, orthopedic specialty). The record describes this supplement as a 30-Day Notice for a process change involving a manufacturer, sterilizer, packager or supplier. The stated change is the addition of a subcontractor, Triangle Manufacturing Co., Inc., to manufacture pedicle screw components used with the TOPS™ implant.

FDA recorded the decision as OK30 on 2026-09-09. That action applies to the supplement and the subcontractor change it covers, not to a new approval of the full TOPS™ System. The source does not describe the pedicle screw specifications, the manufacturing processes affected, or any conditions attached to the decision, and no supporting documents are listed, so those details remain unknown.

Whether the added subcontractor affects component supply, traceability or post-market obligations cannot be determined from this record alone and would require the underlying FDA documents.

FDA approval-order wording

addition of an additional subcontractor for the manufacturing of pedicle screw components to be used with the TOPS implant - Triangle Manufacturing Co., Inc.

Sep 9, 2026 · 30-Day Notice

P220002/S009: TOPS System

FDA’s recorded scope: Approval for the addition of a new inserter (TOPS 2 inserter) and implant design variant (TOPS 2) to be included in the TOPS System

May 29, 2026 · Normal 180 Day Track

P220002/S010: TOPS System

FDA’s recorded scope: introduction of a new plug sorting jig, adjustment to the plug cutting and insertion machine, and minor dimensional changes to the plug and top plate components to and improve sealing performance at the Premia Spine Ltd, Ramat Poleg, Netanya, Isreal and TAV Medical Ltd, Israel facilities

Oct 29, 2025 · 30-Day Notice

P220002: TOPS System

FDA’s recorded scope: Approval for The TOPS System is a motion-preserving spinal implant that is inserted into the lumbar spine via pedicle screws. The TOPS System is intended to stabilize the spine following a lumbar decompression without rigid fixation.The TOPS System is indicated for patients between 35 and 80 years of age with symptomatic degenerative spondylolisthesis up to Grade I, with moderate to severe lumbar spinal stenosis and either the thickening of the ligamentum flavum and/or of the scarring facet joint capsule at one level from L3 to L5.

Jun 15, 2023

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
TOPS SystemP220002/S011
Premia Spine, Ltd.PMA supplementSep 9, 2026FDA
TOPS SystemP220002/S009
Premia Spine, Ltd.PMA supplementMay 29, 2026FDA
TOPS SystemP220002/S010
Premia Spine, Ltd.PMA supplementOct 29, 2025FDA
Premia Spine, Ltd.PMA approvalJun 15, 2023FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.